| Style | Citing Format |
|---|---|
| MLA | Zahiri Z, et al.. "Breaking the Endometriosis–Stroke Axis: Lesion-Focused Hydrogel Reprogramming of Thromboinflammatory Networks." International Immunopharmacology, vol. 185, no. , 2026, pp. -. |
| APA | Zahiri Z, Alborzi S, Hosseini S S M, Sharifian F, Khonsarian Z S, Goldiani N K, Danjeh M, Etezadi A, Amirlatifi S (2026). Breaking the Endometriosis–Stroke Axis: Lesion-Focused Hydrogel Reprogramming of Thromboinflammatory Networks. International Immunopharmacology, 185(), -. |
| Chicago | Zahiri Z, Alborzi S, Hosseini S S M, Sharifian F, Khonsarian Z S, Goldiani N K, Danjeh M, Etezadi A, Amirlatifi S. "Breaking the Endometriosis–Stroke Axis: Lesion-Focused Hydrogel Reprogramming of Thromboinflammatory Networks." International Immunopharmacology 185, no. (2026): -. |
| Harvard | Zahiri Z et al. (2026) 'Breaking the Endometriosis–Stroke Axis: Lesion-Focused Hydrogel Reprogramming of Thromboinflammatory Networks', International Immunopharmacology, 185(), pp. -. |
| Vancouver | Zahiri Z, Alborzi S, Hosseini S S M, Sharifian F, Khonsarian Z S, Goldiani N K, et al.. Breaking the Endometriosis–Stroke Axis: Lesion-Focused Hydrogel Reprogramming of Thromboinflammatory Networks. International Immunopharmacology. 2026;185():-. |
| BibTex | @article{ author = {Zahiri Z and Alborzi S and Hosseini S S M and Sharifian F and Khonsarian Z S and Goldiani N K and Danjeh M and Etezadi A and Amirlatifi S}, title = {Breaking the Endometriosis–Stroke Axis: Lesion-Focused Hydrogel Reprogramming of Thromboinflammatory Networks}, journal = {International Immunopharmacology}, volume = {185}, number = {}, pages = {-}, year = {2026} } |
| RIS | TY - JOUR AU - Zahiri Z AU - Alborzi S AU - Hosseini S S M AU - Sharifian F AU - Khonsarian Z S AU - Goldiani N K AU - Danjeh M AU - Etezadi A AU - Amirlatifi S TI - Breaking the Endometriosis–Stroke Axis: Lesion-Focused Hydrogel Reprogramming of Thromboinflammatory Networks JO - International Immunopharmacology VL - 185 IS - SP - EP - PY - 2026 ER - |